Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pf sporozoite immunization under chloroquine versus mefloquine prophylaxis
NL-OMON35200Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of chloroquine, mefloquine and atovaquone + proguanil in malaria (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Duration of prepatent period after challenge infection. Started Apr 2012; status: active, not recruiting.
02
Drugs
chloroquinemefloquineatovaquone + proguanil
03
Conditions
malaria
Beyond the preview
Go deeper on NL-OMON35200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35200.